Matterworks, the category-defining pioneer unlocking unstructured molecular data for predictive biology, announced new Series A financing. The funding round was led by Lewis & Clark Partners and OMX Ventures, joined by Pillar VC, Germin8 Ventures, Intermountain Ventures, Tarsadia, and others.
How the funding will be used: The company will utilize its Series A proceeds to grow its model as a service (MaaS) business and expand its machine learning and scientific operations.
KEY QUOTES:
“I am delighted to partner with Lewis & Clark and welcome Carolyn Fritz to the Company’s Board of Directors as we accelerate machine intelligence innovations that tackle the unsustainable cost of life science R&D.”
Jack Geremia, Matterworks CEO and Co-Founder
“In collaboration with its customers, Matterworks has repeatedly demonstrated its AI platform provides a step change reduction in the cost and throughput of mass spec quantitation. We are excited to partner with this team in accelerating commercialization of their transformational technology.”
Carolyn Fritz, Operating Partner at Lewis & Clark Partners
“Matterworks is leveraging AI to unlock a new data layer for biology by making mass spectrometry accessible to all biologists. It’s a shift as transformative as single-cell sequencing and we are thrilled to support this exceptional team.”
Craig Asher, Managing Director from OMX Ventures
